HMOs and Gut Development:​ Latest Clinical Evidence​

A healthy gut development after birth contributes to healthy growth, immediate and long-term health. Human milk oligosaccharides (HMOs) are important modulators of early gut microbiome development. With the advancement of technology and research activities, more HMOs are available for infant nutrition. A new randomised, controlled, double-blind, trial shows the beneficial effect of a blend of 5 specific HMOs on early gut development, gut microbiome maturation trajectories and on various growth parameters through toddlerhood. The benefits of these specific HMOs are also shown for infants born by caesarean section.